江苏省中药产业发展现状、存在问题与对策研究

黄滋淳; 张森; 宿树兰; 严辉; 吴啟南; 金世斌; 段金廒

doi:10.14148/j.issn.1672-0482.2023.0580

江苏省中药产业发展现状、存在问题与对策研究

doi: 10.14148/j.issn.1672-0482.2023.0580

黄滋淳^{1, 2, 3,},
张森^{3, 4},
宿树兰^{3, 4},
严辉^{3, 4},
吴啟南^{3, 4, ,},
金世斌^5, ,,
段金廒^{3, 4, ,}

1.
南京中医药大学学科建设处, 江苏南京 210023
2.
南京大学教育研究院, 江苏南京 210023
3.
南京中医药大学药学院, 江苏南京 210023
4.
南京中医药大学江苏省中药资源产业化过程协同创新中心/中药资源产业化与方剂创新药物国家地方联合工程研究中心, 江苏南京 210023
5.
江苏省人民政府研究室, 江苏南京 210024

基金项目:

江苏省人民政府调查研究专项苏简字2046号

江苏省人民政府调查研究专项苏简字2047号

详细信息

作者简介:
黄滋淳, 女，副研究员，E-mail：huangzichun@njucm.edu.cn

通讯作者:
吴启南，男，教授，博士生导师，主要从事中药资源生产及品质评价研究，E-mail: wuqn@njucm.edu.cn

段金廒，男，教授，博士生导师，主要从事中药资源化学研究与资源循环利用研究，E-mail：duanja@163.com

金世斌，男，研究员，博士生导师，主要从事公共政策、社会治理研究，E-mail：kingspin@126.com

中图分类号: F326.12
计量
- 文章访问数: 425
- HTML全文浏览量: 222
- PDF下载量: 50
- 被引次数: 0
出版历程
- 收稿日期: 2022-11-20
- 网络出版日期: 2023-06-12
- 发布日期: 2023-06-10

Analysis of the Development Status, Existing Problems and Countermeasures of Traditional Chinese Medicine Industry in Jiangsu Province

HUANG Zi-chun^{1, 2, 3
,},
ZHANG Sen^{3, 4},
SU Shu-lan^{3, 4},
YAN Hui^{3, 4},
WU Qi-nan^{3, 4
, ,},
JIN Shi-bin^{5
, ,},
DUAN Jin-ao^{3, 4
, ,}

1.
Department of Discipline Construction, Nanjing University of Chinese Medicine, Nanjing 210023, China
2.
Institute of Education, Nanjing University, Nanjing 210023, China
3.
School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
4.
Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
5.
Research Office of Jiangsu Provincial Government, Nanjing 210024, China

摘要

摘要: 分析江苏省中药产业发展现状, 通过纵向历史比较与横向兄弟省份比较, 指出江苏中药产业发展面临的关键问题, 主要包括中药农业及其药材生产和饮片加工产业发展乏力, 种质资源库有待丰富完善; 中药工业及其产品的市场竞争力、创新能力和行业地位亟待提升; 中药产业大多仍停留在线性经济发展模式和生产方式; 商业流通与中药服务体系缺乏规范性等。并进一步提出了江苏中药产业发展的对策与建议: 改革江苏中药管理体制机制, 抢占科研创新高地; 因地制宜合理布局中药材生产, 发展特色中药材种植业; 推动“苏产良药”江苏中医药大品牌建设, 提升科技竞争力和品牌影响力; 加强中药资源循环利用共性关键技术研发。文章还对新发展理念下，教育、科技、人才推动江苏中药产业链高质量发展进行了展望。
- 中医药 /
- 中药产业 /
- 江苏省 /
- 人才培养
Abstract: Based on the analysis of the current situation of the development of the traditional Chinese medicine industry in Jiangsu Province, points out the key problems faced by the development of the traditional Chinese medicine industry in Jiangsu Province by comparing the vertical history with the horizontal counterparts, mainly including the weak development of the traditional Chinese medicine agriculture and its production and processing industry, and the need to enrich and improve the germplasm resource bank; The market competitiveness, innovation ability and industry status of the Chinese medicine industry and its products need to be improved; Most of the traditional Chinese medicine industry still stays in the online economic development mode and production mode; The commercial circulation and traditional Chinese medicine service system are lack of standardization. The countermeasures and suggestions for the development of traditional Chinese medicine industry in Jiangsu are further put forward: reform the management system and mechanism of traditional Chinese medicine in Jiangsu to seize the highland of scientific research and innovation; Rationally arrange the production of traditional Chinese medicine according to local conditions and develop the cultivation of traditional Chinese medicine with characteristics; Promote the construction of the big brand of traditional Chinese medicine in Jiangsu Province, and enhance the scientific and technological competitiveness and brand influence; Strengthen the research and development of common key technologies for the recycling and utilization of traditional Chinese medicine resources. The article also looks forward to how to improve the quality of talent training.
- traditional Chinese medicine /
- Chinese medicine industry /
- Jiangsu Province /
- personnel training

HTML全文

图 1 2021年各省市临床价值中药品牌数量

Figure 1. Number of clinical value Chinese medicine brands by province and city in 2021

下载: 全尺寸图片幻灯片

图 2 2017年至2021年江苏省药品流通行业销售额

Figure 2. Sales of pharmaceutical distribution industry in Jiangsu Province from 2017 to 2021

下载: 全尺寸图片幻灯片

表 1 中成药企业排行榜50强(2021年营收)

Table 1. Top 50 Chinese Patent Medicine Companies (2021 Revenue)

排行	企业规模(2021年营收/亿元)	排行	企业规模(2021年营收/亿元)	排行	企业规模(2021年营收/亿元)
1	广州白云山医药集团股份有限公司(690.1)	18	贵州信邦制药股份有限公司(64.72)	35	广州市香雪制药股份有限公司(29.71)
2	云南白药集团股份有限公司(363.7)	19	李时珍医药集团有限公司(未发布)	36	江苏康缘药业股份有限公司(36.49)
3	修正药业集团股份有限公司(未发布)	20	上海绿谷制药有限公司(未发布)	37	好医生药业集团有限公司(41.21)
4	山东步长制药股份有限公司(157.6)	21	江苏苏中药业集团股份有限公司(未发布)	38	马应龙药业集团股份有限公司(33.82)
5	中国中药控股有限公司(190.0)	22	仁和药业股份有限公司(49.36)	39	亚宝药业集团股份有限公司(27.64)
6	华润三九医药股份有限公司(153.2)	23	广西梧州中恒集团股份有限公司(31.62)	40	金陵药业股份有限公司(28.09)
7	天士力医药集团股份有限公司(79.52)	24	株洲千金药业股份有限公司(36.64)	41	健民药业集团股份有限公司(32.78)
8	北京同仁堂股份有限公司(146.0)	25	广东太安堂药业股份有限公司(22.64)	42	华润江中制药集团有限责任公司(28.74)
9	太极集团有限公司(121.5)	26	九芝堂股份有限公司(37.84)	43	上海和黄药业有限公司(21.18)
10	江西济民可信集团有限公司(410.0)	27	葵花药业集团股份有限公司(44.61)	44	河南羚锐制药股份有限公司(26.94)
11	石家庄以岭药业股份有限公司(101.2)	28	贵州益佰制药股份有限公司(33.47)	45	吉林敖东药业集团股份有限公司(23.04)
12	昆药集团股份有限公司(82.54)	29	东阿阿胶股份有限公司(38.49)	46	雷允上药业集团有限公司(未发布)
13	天津中新药业集团股份有限公司(69.08)	30	黑龙江珍宝岛药业股份有限公司(41.30)	47	颈复康药业集团有限公司(未发布)
14	漳州片仔癀药业股份有限公司(80.22)	31	成都康弘药业集团股份有限公司(36.05)	48	广东众生药业股份有限公司(24.29)
15	天津红日药业股份有限公司(76.71)	32	九信中药集团有限公司(32.39)	49	上海神奇制药投资管理股份有限公司(23.03)
16	济川药业集团有限公司(76.31)	33	上海雷允上药业有限公司(未发布)	50	康臣药业集团有限公司(20.45)
17	浙江康恩贝制药股份有限公司(61.51)	34	贵州百灵企业集团制药股份有限公司(31.12)

下载: 导出CSV

参考文献(18)

[1]	李向英. 传承精华守正创新推动中医药高质量发展[N]. 惠州日报, 2022-11-07(3). LI XY. Inherit the essence, maintain integrity and innovate, and promote the high-quality development of traditional Chinese medicine[N]. Huizhou Daily, 2022-11-07(3).
[2]	纪键. 后疫情时代医药行业的变与不变[J]. 现代商业银行, 2021(1): 72-77. https://www.cnki.com.cn/Article/CJFDTOTAL-JRXK202101020.htm JI J. The change and invariability of pharmaceutical industry in the post-epidemic era[J]. Mod Commer Bank, 2021(1): 72-77. https://www.cnki.com.cn/Article/CJFDTOTAL-JRXK202101020.htm
[3]	吕玲, 杨丰文, 黄明, 等. 改革创新, 全面推进中医药振兴发展: 《"十四五"中医药发展规划》解读[J]. 天津中医药, 2022, 39(6): 681-683. https://www.cnki.com.cn/Article/CJFDTOTAL-TJZY202206001.htm LYU L, YANG FW, HUANG M, et al. Reform and innovation to promote the revitalization and development of traditional Chinese medicine: Interpretation of the "14th Five-Year" Plan for the Development of Traditional Chinese Medicine[J]. Tianjin J Tradit Chin Med, 2022, 39(6): 681-683. https://www.cnki.com.cn/Article/CJFDTOTAL-TJZY202206001.htm
[4]	国家统计局. 2021中国高技术产业统计年鉴[M]. 北京: 中国统计出版社, 2021. National Bureau of Statistics. 2021 China High Technology Industry Statistical Yearbook[M]. Beijing: China statistics press, 2021.
[5]	江苏省人民政府. 自然资源[EB/OL](2022-05-19)[2022-11-29]. http://www.jiangsu.gov.cn/col/col31361/index.html. Jiangsu Provincial People's Government. Natural resources[EB/OL](2022-05-19)[2022-11-29]. http://www.jiangsu.gov.cn/col/col31361/index.html.
[6]	江苏省发展改革委、江苏省卫生健康委、江苏省中医药管理局. 江苏省"十四五"中医药发展规划[M]. 北京: 中国统计出版社, 2021. Jiangsu Provincial Development and Reform Commission, Jiangsu Provincial Health and Health Commission, Jiangsu Provincial Administration of Traditional Chinese Medicine. Jiangsu Province "Fourteenth Five-Year Plan" for the Development of Chinese Medicine[M]. Beijing: China statistics press, 2021.
[7]	胡红霞, 许晨威. 天江药业: 传统中药插上"智造之翼" 开启国际化新征程[J]. 华人时刊, 2020(6): 62-65. https://www.cnki.com.cn/Article/CJFDTOTAL-HRSK202006035.htm HU HX, XU CW. Tianjiang pharmaceutical co., ltd. : Traditional Chinese medicine inserts "wings of wisdom" to start a new journey of internationalization[J]. Chin Times, 2020(6): 62-65. https://www.cnki.com.cn/Article/CJFDTOTAL-HRSK202006035.htm
[8]	朱丽珍. 好消息来了!浙江要扶持道地中药材种植, 推进中医馆建设[EB/OL]. (2021-06-01)[2022-11-29]. https://baijiahao.baidu.com/s?id=1701355352650618819&wfr=spider&for=pc. ZHU LZ. Here comes the good news! Zhejiang is going to support the cultivation of authentic traditional Chinese medicine and promote the construction of traditional Chinese medicine museums[EB/OL]. (2021-06-01)[2022-11-29]. https://baijiahao.baidu.com/s?id=1701355352650618819&wfr=spider&for=pc.
[9]	庞会明, 任娟, 姚毅. 江苏省41家三级中医医疗机构中中药饮片的质量管理现状分析及其改进措施[J]. 抗感染药学, 2021, 18(7): 1060-1063. https://www.cnki.com.cn/Article/CJFDTOTAL-KGYY202107041.htm PANG HM, REN J, YAO Y. Analysis on quality management of TCM decoction pieces in 41 tertiary TCM medical institutions in Jiangsu and their improvement measures[J]. Anti Infect Pharm, 2021, 18(7): 1060-1063. https://www.cnki.com.cn/Article/CJFDTOTAL-KGYY202107041.htm
[10]	黄菊, 李耿, 张霄潇, 等. 新时期下中医药产业发展的有关思考[J]. 中国中药杂志, 2022, 47(17): 4799-4813. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY202217030.htm HUANG J, LI G, ZHANG XX, et al. Relevant thoughts on development of traditional Chinese medicine industry in new era[J]. China J Chin Mater Med, 2022, 47(17): 4799-4813. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY202217030.htm
[11]	上海中药行业协会. 和黄药业、绿谷药业、凯宝药业荣登2021年度中国中药企业TOP100排行榜[EB/OL]. (2022-07-18)[2022-11-29]. http://www.stcma.cn/index.php?m=content&c=index&a=show&catid=15&id=5835. Shanghai Traditional Chinese Medicine Industry Association. Hehuang Pharmaceutical, Green Valley Pharmaceutical, and Kaibao Pharmaceutical were listed on the 2021 Top 100 Chinese Traditional Chinese Medicine Enterprises List[EB/OL]. (2022-07-18)[2022-11-29]. http://www.stcma.cn/index.php?m=content&c=index&a=show&catid=15&id=5835.
[12]	国家药监局. 药品监督管理统计报告(2021年第三季度)[M]. 北京: 中国统计出版社, 2021. State Drug Administration. Statistical Report on Drug Supervision and Management (2021, third quarter)[M]. Beijing: China statistics press, 2021.
[13]	谢洋, 李素云. 关于加快推动中医药科技创新发展的对策研究[J]. 河南科技, 2022, 41(21): 138-141. https://www.cnki.com.cn/Article/CJFDTOTAL-HNKJ202221028.htm XIE Y, LI SY. Research on the countermeasures of accelerating the innovation and development of traditional Chinese medicine science and technology[J]. Henan Sci Technol, 2022, 41(21): 138-141. https://www.cnki.com.cn/Article/CJFDTOTAL-HNKJ202221028.htm
[14]	梅杰, 万兆伟, 李欣咪, 等. 基于文献分析的我国中医药产业发展问题研究[J]. 中医药管理杂志, 2022, 30(19): 4-8. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYG202219002.htm MEI J, WAN ZW, LI XM, et al. Research on the development of Chinese medicine industry based on literature analysis[J]. J Tradit Chin Med Manag, 2022, 30(19): 4-8. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYG202219002.htm
[15]	张萍, 郭晓晗, 金红宇, 等. 2021年全国中药材及饮片质量分析[J]. 中国现代中药, 2022, 24(6): 939-946. https://www.cnki.com.cn/Article/CJFDTOTAL-YJXX202206027.htm ZHANG P, GUO XH, JIN HY, et al. Overall analysis on the quality of Chinese medicinal materials and decoction pieces in 2021[J]. Mod Chin Med, 2022, 24(6): 939-946. https://www.cnki.com.cn/Article/CJFDTOTAL-YJXX202206027.htm
[16]	王旭泉, 许聃. "传统医药国际化"全球企业排名中药"走出去"企业指数发布[N/OL]. 中国日报. https://baijiahao.baidu.com/s?id=1713575333268622376&wfr=spider&for=pc. WANG XQ, XU D. Global Enterprise Ranking of "Traditional Medicine Internationalization" Chinese Medicine "Going Global" Enterprise Index Release[N/OL]. China Daily. https://baijiahao.baidu.com/s?id=1713575333268622376&wfr=spider&for=pc.
[17]	林楠. "2022年中成药综合竞争力50强"出炉, 汉商集团旗下迪康药业上榜[N/OL]. 湖北日报. http://news.hubeidaily.net/mobile/941279.html. LIN N. "Top 50 Comprehensive Competitiveness of Traditional Chinese Patent Medicines and Simple Preparations in 2022" was released, and Dikang Pharmaceutical, a subsidiary of Hanshang Group, was listed[N/OL]. Hubei Daily. http://news.hubeidaily.net/mobile/941279.html.
[18]	汪正龙, 赵光瑞. 中医药产业发展现状与思考[J]. 亚太传统医药, 2022, 18(4): 4-7. https://www.cnki.com.cn/Article/CJFDTOTAL-YTCT202204051.htm WANG ZL, ZHAO GR. Some thoughts on the development status of traditional Chinese medicine industry[J]. Asia Pac Tradit Med, 2022, 18(4): 4-7. https://www.cnki.com.cn/Article/CJFDTOTAL-YTCT202204051.htm